On his part, Madbouly emphasized that this meeting aims to follow up on efforts to advance the pharmaceutical industry ...

Analysis by GlobalData characterises an uncertain pharma landscape, though big pharma CEOs allay investor concern.

Pharma 4.0 is no longer a future ambition; it’s the baseline. The ability to operate with real-time data, integrated systems, ...

Stealth BioTherapeutics, which has been developing a rare disease drug, said it is making contingency plans to close the ...

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating ...

The Saudi Food and Drug Authority (SFDA) has approved Agios' Pyrukynd (mitapivat) for adults with alpha or beta-thalassemia.

HPMA hails Lalit Goel's promotion as state drugs controller- cum-Licensing Authority: Peethaambaran Kunnathoor, Chennai ...

Gerresheimer has announced plans to separate its moulded glass business following a comprehensive strategic review aimed at ...

Shares of German packaging and medical equipment maker Gerresheimer jumped around 4% in early trading on Tuesday after the ...

The impact on innovator contract research, development and manufacturing organisations (CRDMOs) would be relatively lower ...

After Loomer targeted surgeon general nominee and Kennedy ally Casey Means, Means’s brother, Calley, suggested that Loomer’s ...

A total of 7 analyst ratings have been received for Ultragenyx Pharmaceutical, with the consensus rating being Outperform. The average one-year price target stands at $61.14, suggesting a potential ...